FDA Clears Abbott Device to Continuously Track Ketones, Glucose
WASHINGTON, D.C. — U.S. regulators authorized Abbott Diabetes Care’s Libre Duo 10 Day for people with diabetes aged 2 and older, introducing the first U.S. wearable capable of continuously monitoring …
FDA Clears Abbott Device to Continuously Track Ketones, Glucose Read More